中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共72条,第1-10条 帮助

条数/页: 排序方式:
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response 期刊论文  OAI收割
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 卷号: 14, 期号: 1, 页码: 19
作者:  
Yao, Mingyue;  Yan, Wenzhong;  Wang, Yafang;  Zhao, Yu;  Xu, Xiaowei
  |  收藏  |  浏览/下载:5/0  |  提交时间:2025/04/01
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap 期刊论文  OAI收割
MOLECULES, 2024, 卷号: 29, 期号: 19, 页码: 26
作者:  
Zhang, Han;  Shen, Qianqian;  Hu, Zhu;  Wu, Pei-Qian;  Chen, Yi
  |  收藏  |  浏览/下载:4/0  |  提交时间:2024/11/26
NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe 期刊论文  OAI收割
EBIOMEDICINE, 2023, 卷号: 98, 页码: 18
作者:  
Wang, Bo;  Tang, Chu
  |  收藏  |  浏览/下载:26/0  |  提交时间:2024/02/22
The intrinsic effects of using rhenium gaskets in hydrothermal diamond anvil cell experiments on background fluorescence, contamination, and redox control 期刊论文  OAI收割
CHEMICAL GEOLOGY, CHEMICAL GEOLOGY, 2023, 2023, 卷号: 632, 632, 页码: 14, 14
作者:  
Cheng, Nanfei;  Chou, I. -Ming;  Wan, Ye;  Wang, Ruoheng;  Zhang, Haiyan
  |  收藏  |  浏览/下载:25/0  |  提交时间:2023/10/07
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612
作者:  
Wang, Xiaomin;  Xu, Jun;  Sun, Yiming;  Cao, Siyuwei;  Zeng, Hanlin
  |  收藏  |  浏览/下载:44/0  |  提交时间:2023/10/17
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKK? and overcomes gefitinib resistance in non-small cell lung cancer 期刊论文  OAI收割
CANCER BIOLOGY & MEDICINE, 2022, 卷号: 19, 期号: 8, 页码: 1172-1192
作者:  
He, Ting;  Gao, Yinglei;  Fang, Yanfen;  Zhang, Yangming;  Zhang, Shuwei
  |  收藏  |  浏览/下载:26/0  |  提交时间:2024/03/21

A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo

期刊论文  OAI收割

BIOCHEMICAL PHARMACOLOGY, 2022, 卷号: 201, 页码: 12
作者:  
Li, Yin-Ru;  Liu, Fang-Fang;  Liu, Wen-Bo;  Zhang, Yi-Fan;  Tian, Xin-Yi
  |  收藏  |  浏览/下载:37/0  |  提交时间:2022/08/16
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo 期刊论文  OAI收割
BIOCHEMICAL PHARMACOLOGY, 2022, 卷号: 201, 页码: 115070
作者:  
Li, Yin-Ru;  Liu, Fang-Fang;  Liu, Wen-Bo;  Zhang, Yi-Fan;  Tian, Xin-Yi
  |  收藏  |  浏览/下载:28/0  |  提交时间:2024/03/21
Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands 期刊论文  OAI收割
MOLECULES, 2021, 卷号: 26, 期号: 23, 页码: 19
作者:  
Lu, Yingxin;  Sun, Danwen;  Xiao, Donghuai;  Shao, Yingying;  Su, Mingbo
  |  收藏  |  浏览/下载:45/0  |  提交时间:2022/06/15
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 9
作者:  
Zhou, Yu-bo;  Zhang, Yang-ming;  Huang, Hong-hui;  Shen, Li-jing;  Han, Xiao-feng
  |  收藏  |  浏览/下载:73/0  |  提交时间:2021/11/04